Korean Clinical Trials Prove Exosomes, Peptides and Spicules Outperforms Retinol in Anti-Ageing
Modern Molecules introduces medical-grade skincare technology and the, revolutionary REGENEX™ Renewal Serum Using a technology originally developed to regenerate burned skin, the REGENEX™ complex is harnessed for the first time to regenerate aged skin back to youth. SINGAPORE, Oct. 3, 2024 /PRN
Reju opens Regeneration Hub Zero, its first textile to textile hub, in Frankfurt, Germany
PARIS, Oct. 3, 2024 /PRNewswire/ — Reju™, the progressive textile to textile regeneration company has opened its first operating unit – Regeneration Hub Zero – in Frankfurt Germany. This is Reju’s first major milestone after being incorporated just 12 months ago in Paris,
DFRobot Invited to Attend the International Forum of UNESCO Chairs and Partners in Addis Ababa
SHANGHAI, Oct. 3, 2024 /PRNewswire/ — The International Forum of UNESCO Chairs and Partners, organized by the African Union Commission in collaboration with UNESCO, took place successfully in Addis Ababa, Ethiopia, from September 30 to October 2, 2024. The forum’s theme, “Transform
Valmet to supply an OptiConcept M board making line to Anhui Linping Circular Development in China
Valmet Oyj press release, October 3, 2024, at 9:30 a.m. EEST ESPOO, Finland, Oct. 3, 2024 /PRNewswire/ — Valmet is to supply an OptiConcept M board making line with automation and services to Anhui Linping Circular Development in China. The new board line PM 8 will produce recycled liner gr
Energy Climate Tech Leader ENlighten Surpasses 6.2GW in Solar Capacity on ‘SOLAR CHAMP’
– Innovatively Addressing the Climate Crisis with Integrated Energy Solutions SEOUL, South Korea, Oct. 3, 2024 /PRNewswire/ — Enlighten, a leading South Korean energy climate tech company, has announced that its solar power asset management platform, SOLAR CHAMP, has exceeded 6.2GW of
Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment
Financing to advance lead asset RTX001, an engineered, pro-regenerative macrophage therapy with first-in-class potential for end-stage liver disease, into the Phase I/II EMERALD study Proceeds also strengthen manufacturing capabilities and support macrophage therapy pipeline growth in inflammatory a
SINGAPORE’S FAVOURITE INDIAN RESTAURANT, SANSARA, MARKS ITS FIRST YEAR OF OPENING
SINGAPORE, Oct. 3, 2024 /PRNewswire/ — Grand Copthorne Waterfront Hotel Singapore celebrates the first anniversary of SanSara, ranked #1 on TripAdvisor among Indian restaurants in Singapore. To commemorate this and usher in the festive season, the restaurant is launching a Lucknowi feast wit
BrightNight Secures Development Approval for Victoria’s Largest Hybrid Renewable Energy Project
The Mortlake Energy Hub represents an investment of $700 million and is expected to create more than 300 local jobs VICTORIA, Australia, Oct. 3, 2024 /PRNewswire/ — BrightNight, the next-generation global renewable power producer, has received development approval from the Victorian governmen
Veritas Genetic participates in a groundbreaking study highlighting the importance of polygenic risk scores in the clinical management of breast cancer patients
The study, conducted in collaboration with the Department of Biomedicine and Prevention at the University of Rome Tor Vergata and Tor Vergata University Hospital, underscores the relevance of polygenic risk scores (PRS) in risk stratification for patients with a genetic predisposition to breast can
FOMO Pay partners Visa to expand digital payments acceptance for Small Medium Enterprises in Singapore
SINGAPORE, Oct. 3, 2024 /PRNewswire/ — FOMO Pay, a leading Singapore-based major payment institution announced a strategic partnership today with Visa, the world’s leader in digital payments. Through this collaboration, FOMO Pay will integrate Visa’s QR into the SGQR network, enabl
